Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports-August 2024-www.financetom.com

Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports

Sep 12, 2025 3:14 AM

Sept 12 (Reuters) - Kenvue's ( KVUE ) interim Chief

Executive Officer Kirk Perry met Robert F. Kennedy Jr. to try

and dissuade the U.S. health secretary from including Tylenol as

a potential cause of autism in an upcoming report, the Wall

Street Journal reported on Friday, citing a person familiar with

the matter.

Previous page： 1911 Gold Provides High-Grade Intersections from True North Gold Project in Manitoba Next page： Lithia Buys Elite Porsche, Audi Stores In High-End LA Markets

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

1911 Gold Provides High-Grade Intersections from True North Gold Project in Manitoba

Nov 11, 2025

08:09 AM EST, 11/11/2025 (MT Newswires) -- 1911 Gold ( AUMBF ) reported Tuesday the latest high-grade assays from the True North gold project within the Rice Lake property in Manitoba. Highlights from the San Antonio West target include 24.83 grams per tonne (g/t) gold over 2.60 meters, including 46.00 g/t gold over 1.00 meters, including 63.20 g/t gold over...

Lithia Buys Elite Porsche, Audi Stores In High-End LA Markets

Nov 11, 2025

Lithia & Driveway, part of Lithia Motors, Inc. ( LAD ) , announced on Tuesday the acquisition of Porsche Beverly Hills and Audi Santa Monica dealerships. Lithia Motors ( LAD ) is the parent entity, while Lithia & Driveway reflects its combined physical dealership network and online retail platform. The addition of these two premium stores is expected to contribute...

EnGene's Mid-Stage Trial Shows Improved Complete Response Rate in Non-Muscle Invasive Bladder Cancer Patients

Nov 11, 2025

08:09 AM EST, 11/11/2025 (MT Newswires) -- EnGene ( ENGN ) said Tuesday that additional preliminary data from the pivotal cohort of its mid-stage trial of detalimogene voraplasmid showed an improved complete response rate of 62% in six months for patients with high-risk, Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer patients with carcinoma in situ. The data also showed low...

Kits Eyecare Reports Record Sales Week With Revenue Up 27% to $4.5 Million

Nov 11, 2025

08:07 AM EST, 11/11/2025 (MT Newswires) -- Kits Eyecare ( KTYCF ) Tuesday announced record-breaking results for the week of Nov. 1 to Nov. 8. Total sales jumped 27% to $4.48 million, with repeat customers contributing 66% of total revenue. The company said 10,000 glasses were ordered, and glasses revenue rose 50%. Marketing spend took up 14.5% of revenue, or...